scispace - formally typeset
Search or ask a question

What cancers disqualifies you from donating plasma? 

Answers from top 12 papers

More filters
Papers (12)Insight
This report lends insight into progress toward an appropriate therapy for blood cancers using non-thermal DBD plasma.
Together, these findings better define the optimal window for donating convalescent plasma useful for immunotherapy of COVID-19 patients and reveal important predictors of an ideal plasma donor, including age and COVID-19 disease severity score.
WHAT IS KNOWN ALREADY Infertile women are at higher risk of hormone-sensitive cancers.
Plasma hTERT DNA has the potential to be a broad tumor marker for common cancers.
Our prospective findings support this, indicating that neither body weight nor the amounts of plasma donated per kilogram of body weight per session were associated with ceasing from donating for medical reasons, no matter whether related or unrelated to the plasma donations themselves.
Plasma FEAT levels were significantly higher in the presence of cancers. These findings suggest that FEAT is a candidate for applications in early diagnosis and prevention of some cancers.
plasma D dimer level was positively correlated with clinical stage of solid cancers.
Open accessJournal Article
6 Citations
What you eat can also have an effect on whether you develop cancer.
Open accessJournal Article
Chandradhar Dwivedi, Dixit M, Hardy Re 
12 Citations
Plasma sialyltransferase determination may be useful in the followup of patients with a variety of cancers.
Open accessJournal Article
Chandradhar Dwivedi, Dixit M, Hardy Re 
12 Citations
These results indicate that plasma sialyltransferase is significantly elevated in patients with a variety of cancers.